Recent Progress in the Prevention of Serogroup B Meningococcal Disease

The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease. Over a period of 4 decades, vaccine development has focused on subcapsular protein antigens, first with outer membrane vesicle (OMV) vaccines again...

Descripción completa

Detalles Bibliográficos
Autores principales: Feavers, Ian M., Maiden, Martin C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424234/
https://www.ncbi.nlm.nih.gov/pubmed/28356256
http://dx.doi.org/10.1128/CVI.00566-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424234/
https://www.ncbi.nlm.nih.gov/pubmed/28356256
http://dx.doi.org/10.1128/CVI.00566-16

Ejemplares similares